baber/WOPTO huggingface dataset:
Patent CA-2709277-A1 (CA)
Inventor: VERBOOM GILLES M
IPC: A61Q5/06
Filed: 2008-12-10
Abstract: Provided is a hair-styling composition, which preferably includes a poly(vinylamine-vinylformamide) copolymer, a polyvinylpyrrolidone, and water, wherein the composition when applied to human hair, exhibits at least about 50% curl retention after about 2 hours under conditions of about 90% relative humidity and about 75° F. Also provided are methods for styling mammalian hair and controlling frizz with the composition of the present invention, and a personal care product that includes the composition of the present invention.
Patent CA-2710443-A1 (CA)
Title: Antimicrobial cellulose sponge and method of making
Inventor: TRUONG MYHANH T
IPC: A47K7/02
Filed: 2008-12-08
Abstract: Biguanide bonded within a cellulose sponge inhibits or prevents the growth of microorganisms such as bacteria, mold, and fungus within the cellulose sponge over the useful life of the cellulose sponge.
Patent CA-2710467-A1 (CA)
Inventor: VARDARO ANTONIO
IPC: B65G1/06
Filed: 2010-07-20
Abstract: A dispenser for packets comprises a plurality of horizontal rows comprising a plurality of side by said dispenser compartments. Each compartment defines a channel for receiving a horizontal stack of packets and comprises a front edge. A movement imparting assembly is mounted within each compartment and comprises a pusher member for engaging the horizontal stack of packets. The movement imparting assembly provides for the pusher member to selectively push forward the horizontal stack of packets so as to push at least one of the packets in the compartment off the edge thereof for retrieval. Sensor are mounted to the dispenser so as to detect dispensing of packets and to communicate this information to a controller.
Patent CA-2711446-A1 (CA)
Inventor: REN PINGDA
IPC: C07D217/22
Filed: 2009-01-05
Abstract: Chemical entities that modulate PD kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with P13 kinase activity are described herein.
Patent CA-2711646-A1 (CA)
Inventor: LIU KUI
IPC: G01N33/573
Filed: 2009-01-19
Abstract: The invention relates to methods to be used in the maturation of ovarian follicles and oocytes. More specifically, the invention concerns the use of inhibitors of the phosphatase PTEN, such as oxovanadate and peroxovanadate complexes, in methods for in vitro and in vivo maturation of follicles and oocytes.
Patent CA-2713269-A1 (CA)
Inventor: ALFANI ROBERTA
IPC: C04B28/16
Filed: 2008-01-31
Abstract: The present invention relates to a solid mixture and a coating or painting based on a sulfo-aluminous or sulfo-ferroaluminous clinker, the relative use as coating or painting of cementitious- and non- cementitious-based supports, in particular as coating or painting of cementitious -based pipes.
Patent CA-2715165-A1 (CA)
Inventor: TAKAHASHI YUKI
IPC: B32B7/12
Filed: 2010-09-13
Abstract: In an outer covering sheet of an absorbent product, first, second and third adhesive layer elements each extending in a left-right direction are formed on a second covering sheet by spiral spray application. Each of these adhesive layer elements has wide width parts and narrow width parts which are continuous with the wide width parts, respectively. Therefore, hot melt adhesive can be stably discharged across the entire length of the adhesive layer element, unlike in the case where only wide width parts are formed intermittently. As the result, it is possible to obtain the outer covering sheet which is a sheet member having the adhesive layer elements with desired shapes where unevenness is decreased. And in the absorbent product which is manufactured with use of the sheet member, comfort level of the wearer can be prevented from decreasing due to unevenness of thickness of the adhesive layer elements.
Patent CA-2715962-A1 (CA)
Title: Utilisation de 2,4-pyrimidinediamines pour le traitement de l'atherosclerose
Inventor: MASUDA ESTEBAN
IPC: A61P9/10
Filed: 2009-02-20
Abstract: Linvention concerne de nouveaux procédés et de nouvelles compositions pour la prévention et le traitement de toutes les formes dathérosclérose avec des composés de 2,4-pyrimidinediamines. Linvention concerne également le revêtement de dispositifs prothétiques, tels que des endoprothèses, avec les composés de linvention pour la prévention et/ou le traitement de la resténose.
Patent CA-2718401-A1 (CA)
Inventor: DAILEY KEVIN E
IPC: C12P7/02
Filed: 2009-03-12
Abstract: A process for the use of low concentration levels of Erythromycin to eliminate or control the growth of unwanted or undesirable bacteria (contaminating bacteria) in the fermentation production of alcohols without inhibition of the growth or replication of the yeast.
Patent CA-2720081-A1 (CA)
Inventor: HARRISON JAMES J
IPC: C08F8/46
Filed: 2009-03-18
Abstract: Copolymers made with quasi-living polyolefins and unsaturated acidic reactants, dispersants using same, and methods of making same are provided. Under one aspect, a copolymer of an unsaturated acidic reactant and high molecular weight polyolefin, wherein the polyolefin comprises an exo-olefin terminated quasi-living polymeric product, is provided. The quasi-living polymeric product is formed, e.g., by forming a quasi-living cationic polyolefin under suitable quasi-living conditions, and contacting the cationic polyolefin with an agent selected to convert the cationic polyolefin to the exo-olefin terminated quasi-living polymeric product. The cationic polyolefin can be formed, e.g., by one of (a) contacting a cationically polymerizable monomer with an initiator, in the presence of a Lewis acid; (b) ionizing a tert-halide terminated polyolefin with a Lewis acid; (c) contacting a preformed polyolefin with a Lewis acid; or (d) contacting a cationically polymerizable monomer with an inifer carrying at least two tertiary halogens under cationic polymerization conditions.
Patent CA-2720139-A1 (CA)
Inventor: OSTERLING JACOB
IPC: H04W88/08
Filed: 2008-11-17
Abstract: A distributed radio base station includes a first radio equipment controller (REC) node (12), a second radio equipment controller (REC) node (14), and a radio equipment (RE) node (16) for transceiving information over a radio interface with one or more radio terminals. The first REC node and the second REC node are physically separate from the RE node. The first REC node and/or the second REC node are/is connected to the RE node by a transmission link. Synchronization reference information is provided to one of the REC and RE nodes. The synchronization reference information in the one node is compared with timing information received from another of the REC nodes to generate a timing difference. The timing difference is used to adjust a timing unit at the another node in order to achieve timing synchronization between the RE node, the first REC node, and the second REC node.
Patent CA-2720858-A1 (CA)
Inventor: JEROSCH-HEROLD MICHAEL
IPC: A61B5/00
Filed: 2008-04-11
Abstract: Embodiments provide a noninvasive quantitative method for detecting extent and/or types of fibrosis in the heart.  In embodiments, information pertaining to the extent and/or types of fibrosis may aid in the diagnosis of specific cardiac diseases and heart failure and/or may assist in determining suitable treatment options.  Embodiments provide methods and apparatuses for determining the extent of fibrosis in viable and nonviable myocardium, which may then be correlated to heart disease and failure.  Thus, in an embodiment, a method of screening individuals for the purpose of heart disease or heart failure prevention may be provided using the detection methodology described herein.
Patent CA-2721932-A1 (CA)
Inventor: MAHENDRAN ARUNGUNDRAM C
IPC: H04W4/90
Filed: 2009-05-06
Abstract: A mobile device/UE identifies calls to or callbacks from a Public Safety Access Point (PSAP) in order to provide priority handling.  When the UE does not detect that the call being made is an emergency call, then the network facilitates identification during call establishment of the emergency nature. The network identifies the call as emergency call in a SIP response by setting the Priority header to distintive value (e.g.,"emergency-call") or the "P-Asserted-Identity to a distinctive value (e.g., urn:services:sos). When PSAP chooses to call back the mobile/UE, the mobile/UE can terminate any ongoing calls and accept this call from the PSAP and can disable other supplementary services (e.g., call waiting, three-way calling etc.) during the call. A P-Asserted-Identity of the incoming call is set to a distinctive location associated with PSAP  (e.g., um:services:sos). Alternatively, the incoming call has a Priority header set to a distinctive value (e.g., "emergency", "emergency-callback").
Patent CA-2723772-A1 (CA)
Inventor: KANADE PARAG MOHAN
IPC: H04W48/16
Filed: 2009-05-19
Abstract: A method and apparatus for channel acquisition using a mobile station include obtaining geographic information of at least one wireless communication sys-tems using one or more systems, respec-tively. The one or more channels are priori-tized on a preferred roaming list based on the geographic information, and it is deter-mined whether any of the prioritized one or more channels on the preferred roaming list are also on a most recently used (MRU) list. The mobile station attempts to acquire at least one of the prioritized one or more channels that is also on the MRU list.
Patent CA-2725024-A1 (CA)
Inventor: CARMODY MICHAEL A
IPC: E21B7/20
Filed: 2010-12-10
Abstract: A method of running a first tubular within a second tubular includes running the first tubular into the second tubular past at least one lateral extending from the second tubular, running a diverting too] at the first tubular with the running of the first tubular, withdrawing the first tubular from the second tubular until an end of the first tubular is beyond a junction between the at least one lateral and the second tubular and, running the first tubular into the at least one lateral.
Patent CA-2727465-A1 (CA)
Inventor: BIELICKI JOHN K
IPC: C07K7/08
Filed: 2009-06-17
Abstract: The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., Apo AI and Apo E), and having high selectivity for ABAC1 that parallels that of full-length apolipoproteins.  The invention also provides compositions comprising such polypeptides, methods of identifying, screening and synthesizing such polypeptides, and methods of treating, preventing or diagnosing diseases and disorders associated with dyslipidemia, hypercholesterolemia and inflammation.
Patent CA-2734227-A1 (CA)
Title: High yielding soybean variety xb26e11
Inventor: CARDEN BRIAN A
IPC: A01H5/10
Filed: 2011-03-21
Abstract: According to the invention, there is provided a novel soybean variety designated XB26E11. This invention thus relates to the seeds of soybean variety XB26E11, to the plants of soybean XB26E11 to plant parts of soybean variety XB26E11 and to methods for producing a soybean plant produced by crossing plants of the soybean variety XB26E11 with another soybean plant, using XB26E11 as either the male or the female parent.
Patent CA-2734555-A1 (CA)
Inventor: LUNDQUIST RASMUS
IPC: A61K35/15
Filed: 2009-08-24
Abstract: A blood product (10), a method for preparing the blood product, a blood product obtainable by the method and a blood product preparing container means. The blood product comprises components from whole blood, especially fibrin, thrombocytes and leukocytes. The blood product (10) comprises a first layer (21), a second layer (22) and a third layer (23). The second layer (22) is adjacent to the first layer (21) and the third layer (23). The first layer (21) defines a first outer surface (24) of the blood product (10) and the third layer (23) defining a second outer surface (25) of the blood product (10). The first layer (21) comprises a majority of fibrin, the second layer (22) comprises a majority of thrombocytes and the third layer (23) comprises a majority of leukocytes.
Patent CA-2736113-A1 (CA)
Inventor: HSIAO TSUNG YU
IPC: A61K38/00
Filed: 2009-09-03
Abstract: The present invention provides for an efficient process for making Pramlinitide, as well as novel intermediates for the making of the same.
Patent CA-2739469-A1 (CA)
Inventor: NITZEL GREGORY PAUL
IPC: A61K39/12
Filed: 2009-10-16
Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Torque teno virus ("TTV"), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine TTV  genotypes and isolates. Diagnostic and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include vaccines that provide TTV ORF1 protein, or peptide fragments thereof, as antigen.
Patent CA-2740617-A1 (CA)
Inventor: LORD STEPHEN M
IPC: C01B33/04
Filed: 2009-11-02
Abstract: A reactor for hydrogenation of a silicon tetrahalide and metallurgical grade silicon to trihalosilane includes a bed of metallurgical silicon particles, one or more gas entry ports, one or more solids entry ports, one or more solids drains and one or more ports for removing the trihalosilane from the reactor., Fresh surfaces are generated on the bed particles by internal grinding and abrasion as a result of entraining feed silicon particles in a silicon tetrahalide/hydrogen feed stream entering the reactor and impinging that stream on the bed of silicon particles. This has the advantages of higher yield of the trihalosilane, higher bumup rate of the MGS, removal of spent MGS as a fine dust carryover in the trihalosilane effluent leaving the reactor and longer times between shutdowns for bed removal.
Patent CA-2741848-A1 (CA)
Title: Retractable base system for all types of volleyball unipost
Inventor: LEONI OTTAVIO
IPC: E04H12/22
Filed: 2011-05-24
Abstract: In any kind of volleyball post there is a base which slides into a socket in the floor holding the post upright and supporting it while being played on. However when the volleyball post is not in a socket on the floor this base protrudes from the bottom of the post and does not allow the post to stand vertically by by itself When putting the post into the socket in the ground the post must be positioned so that the base will slide squarely into the socket. When removing the post, the base (and entire post) must be pulled directly upward out of the socket and completely out of the ground before it can be wheeled away in the invention of the retractable base system, the base retracts telescopically into the post and so the entire volleyball post must not be lifted out of the ground but the base must be only manually slid upward into the post and locked in the up position. This invention requires the user only to slide the base up into the post or down into the socket using a handle attached to the base. By using the sliding base system, the entire volleyball post never needs to be lifted off of the ground making it much easier to install or remove the post into the socket in the floor Because the base slides into the post, the entire volleyball post can also be stored standing freely on its own
Patent CA-2744092-A1 (CA)
Inventor: SINCLAIR BILL
IPC: G01N21/55
Filed: 2009-12-02
Abstract: A technique for high sensitivity evanescent field molecular sensing employs a detection scheme that simultaneously couples a polarized beam to a single mode of a waveguide, and couples the polarized beam out of the waveguide to specularly reflect the beam by the same grating. Strong interaction with the single (preferably TM) mode is provided by using a silicon on insulator (SOI) wafer having a waveguide thickness chosen between 10-400 nm so that the majority of the mode field strength spans the evanescent field. Well known, robust techniques for producing a grating on the waveguide are provided. Interrogation from a backside of the SOI wafer is taught.
Patent CA-2744478-A1 (CA)
Inventor: BATMAZ EDIZ
IPC: A23L3/02
Filed: 2011-06-23
Abstract: Systems and methods for monitoring various process parameters, primarily in connection with processes for the sterilization of particulate foods in a continuous thermal process, make use of application specific integrated circuits (ASIC) that provide process-related data for batch or continuous thermal treatment when the circuit is embedded in a particle subjected to such treatment. The preferred methods are described in connection with process design, and with at least near real-time process control using process data provided by such circuits.
Patent CA-2747437-A1 (CA)
Title: Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acid
Inventor: CISZEWSKI LECH
IPC: A61P37/00
Filed: 2009-12-16
Abstract: This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this salt, to processes for forming this salt and to its use in medical treatment. In addition, the present invention also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment.
Patent CA-2748184-A1 (CA)
Inventor: KELLEY PAUL V
IPC: B65D90/12
Filed: 2010-01-04
Abstract: Method and system for handling a plurality of hot-filled and capped containers having temporary de-formations or distortions caused by vacuums induced in the containers For each container, temporary deformations are confined or directed to a particular portion of the con-tainer Annular hoop rings can be provided to confine the temporary deformations to a smooth sidewall portion of the container between the annular hoop rings Alternative-ly, one or more supplemental vacuum panels can be pro-vided to confine or direct the temporary deformation thereto The annular hoop rings and the one or more sup-plemental vacuum panels can provide for substantially sta-ble touch points for the container The containers are con-veyed with temporary deformations such that substantially stable contact points of each container are in contact with corresponding substantially stable contact points of other containers
Patent CA-2752451-A1 (CA)
Inventor: MAECHLING SIMON
IPC: C07D239/48
Filed: 2010-02-05
Abstract: The present application relates to novel aminopyrimidinamides, to processes for their preparation and to their use for controlling animal pests, especially arthropods, in particular insects.
Patent CA-2753236-A1 (CA)
Inventor: MCIVER EDWARD GILES
IPC: A61P19/02
Filed: 2010-03-04
Abstract: The invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein:  R1 is -NR7(CO)R11; R2 is aryl, heteroaryl, fused aryl-C3-6-heterocycloalkyl or fused heteroaryl-C3-6- heterocycloalkyl, each of which is optionally substituted; each R7 is selected from hydrogen, C1-6-alkyl and C3-7-cycloalkyl, wherein said C1-6-alkyl is optionally substituted by one or more halogens; each R11 is independently selected from C1-6-alkyl, C3-7-cycloalkyl, C1-6alkyl-C3-7-cycloalkyl, C^-heterocycloalkyl, aryl and heteroaryl, each of which may be optionally substituted. Further aspects of the invention relate to pharmaceutical compositions comprising the same, and methods for treating or preventing a disorder selected from cancer, septic shock, Primary open Angle Glaucoma (POAG), hyperplasia, rheumatoid arthritis, psoriasis, artherosclerosis, retinopathy, os-teoarthritis, endometriosis, chronic inflammation and Alzheimer's disease.  Another aspect of the invention relates to the use of a compound as described above in the preparation of a medicament for the prevention or treatment of a disorder caused by, associated with or accompanied by any abnormal kinase activity, wherein the kinase is selected from TBK1, ERK8, CDK2, MARK3, YES 1, VEG-FR, IKKepsilon and combinations thereof.
Patent CA-2755611-A1 (CA)
Inventor: MIKHAEIL SAMI GAMIL YOUSSEF
IPC: G16H10/60
Filed: 2011-10-20
Abstract: A pharmacy workflow platform and prescription checking and medicament dispensing station and method comprising (a) script display means; (b) scanning means for providing script data and stock bottle label data in electronic format from the prescription and a stock bottle label; (c) CPU means comprising i) means for receiving and storing the script data and stock bottle data in electronic format; ii) means for transferring the script data to the script display means to effect display of the script; iii) means cooperable with medicament dispensing weighing and counting means; (d) medicament-dispensing weighing means in communication with the CPU means;; and (e) control means for controlling the CPU means. Medication is dispensed in a more safe, efficient and cost-effective manner.
Patent CA-2756934-A1 (CA)
Title: Oral care compositions comprising tetrapotassium pyrophosphate
Inventor: GU BEN
IPC: A61K33/42
Filed: 2009-04-02
Abstract: The invention relates to desensitizing, anti-tartar oral care compositions comprising an orally acceptable vehicle and an effective desensitizing and anti-tartar amount of tetrapotassium pyrophosphate.
Patent CA-2757200-A1 (CA)
Title: Method for manufacturing semiconductor substrate
Inventor: SASAKI MAKOTO
IPC: H01L21/20
Filed: 2010-09-28
Abstract: In the provided method for manufacturing a semiconductor substrate, a first silicon carbide substrate (11) has a first top surface (F1) and a first lateral surface. A second silicon carbide substrate (12) has a second top surface (F2) and a second lateral surface. The second lateral surface is disposed such that a gap, which has an opening between the respective first and second top surfaces (F1, F2) of the first and second silicon carbide substrates (11, 12), is formed between the first and second lateral surfaces. A plug part (70) that plugs the gap is provided above the opening.  Depositing a sublimate from the first and second lateral surfaces onto the plug part (70) forms a joining part (BDa) that connects the first and second lateral surfaces so as to plug up the opening. After the step in which the joining part (BDa) is formed, the plug part (70) is removed.
Patent CA-2757564-A1 (CA)
Title: Hydrophilic diagnostic devices for use in the assaying of biological fluids
Inventor: MEATHREL WILLIAM G
IPC: G01N33/558
Filed: 2002-04-19
Abstract: A lateral flow in-vitro diagnostic device is disclosed which comprises a housing, means in the housing to introduce a sample to be assayed in the device, means in the housing for fluid collection, and a backing strip having spaced apart first and second ends. The backing strip has a surface with hydrophilic properties. The surface comprises either a hydrophilic heat-sealable adhesive or a hydrophilic pressure sensitive adhesive. The adhesive increases the surface energy of a fluid flow path in the device and decreases the surface tension of a biological fluid flowing along the fluid flow path.